Skip to main content
Top
Published in: Surgical Endoscopy 8/2007

01-08-2007

Continuous perioperative insulin infusion therapy for patients with type 2 diabetes undergoing bariatric surgery

Authors: R. Blackstone, J. Kieran, M. Davis, L. Rivera

Published in: Surgical Endoscopy | Issue 8/2007

Login to get access

Abstract

Background

Continuous insulin infusion (CII) is proven to decrease morbidity and mortality in surgical critical care patients. This study compared standard insulin therapy with CII in type 2 diabetes patients undergoing elective bariatric surgical procedures in a community hospital.

Methods

A retrospective review investigated 350 bariatric surgical patients with type 2 diabetes who underwent perioperative treatment of hyperglycemia using either standard insulin therapy or CII. The 182 patients in group 1 underwent glucose monitoring and subcutaneous insulin treatment every 6 h, whereas the 168 patients in group 2 had CII treatment beginning in the preoperative holding area and monitored hourly for the next 24 h. The two groups were similar in demographic characteristics.

Results

There were no significant hypoglycemic episodes with perioperative CII. The mean perioperative insulin required was 5.8 U/h. The patients receiving CII had fewer postprocedure cholecystectomies, but a higher number of port-site infections.

Conclusions

Perioperative CII can be administered safely to diabetic patients undergoing bariatric surgery. The insulin requirements in this population are higher than expected. Our study showed a decrease in the number of postoperative cholecystectomies in the CII group, but no effect on the stricture rate and an increase in the number of patients with postoperative port-site infections.
Literature
1.
go back to reference Hauner H (2004) Managing type 2 diabetes mellitus in patients with obesity (review). Treat Endocrinol 3: 223–232PubMedCrossRef Hauner H (2004) Managing type 2 diabetes mellitus in patients with obesity (review). Treat Endocrinol 3: 223–232PubMedCrossRef
2.
go back to reference Dixon JB, Pories WJ, O’Brien PE, Schauer PR, Zimmet P (2005) Surgery as an effective early intervention for diabesity: why the reluctance? (review). Diabetes Care 28: 472–474PubMedCrossRef Dixon JB, Pories WJ, O’Brien PE, Schauer PR, Zimmet P (2005) Surgery as an effective early intervention for diabesity: why the reluctance? (review). Diabetes Care 28: 472–474PubMedCrossRef
3.
go back to reference MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ (1997) The gastric bypass operation reduces the progression and mortality of non–insulin-dependent diabetes mellitus. J Gastrointest Surg 1: 213–220PubMedCrossRef MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ (1997) The gastric bypass operation reduces the progression and mortality of non–insulin-dependent diabetes mellitus. J Gastrointest Surg 1: 213–220PubMedCrossRef
4.
go back to reference Jacobs ML, Elte JW, van Ouwerkerk BM, Janssens EN, Schop C, Knoop JA, Hoogma RP, Groenendijk R, Weber RF (1997) Effect of BMI, insulin dose, and number of injections on glycaemic control in insulin-using diabetic patients. Studygroup Diabetes Rijnmond (SDR). Neth J Med 50: 153–159PubMedCrossRef Jacobs ML, Elte JW, van Ouwerkerk BM, Janssens EN, Schop C, Knoop JA, Hoogma RP, Groenendijk R, Weber RF (1997) Effect of BMI, insulin dose, and number of injections on glycaemic control in insulin-using diabetic patients. Studygroup Diabetes Rijnmond (SDR). Neth J Med 50: 153–159PubMedCrossRef
5.
go back to reference Ballantyne GH, Gumbs A, Modlin IM (2005) Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin, and resistin (review). Obes Surg 15: 692–699PubMedCrossRef Ballantyne GH, Gumbs A, Modlin IM (2005) Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin, and resistin (review). Obes Surg 15: 692–699PubMedCrossRef
6.
go back to reference Mannan MA, Rahman MS, Siddiqui NI (2004) Obesity management in patients with type 2 diabetes mellitus (review). Mymensingh Med J 13: 95–99PubMed Mannan MA, Rahman MS, Siddiqui NI (2004) Obesity management in patients with type 2 diabetes mellitus (review). Mymensingh Med J 13: 95–99PubMed
7.
go back to reference Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I (2005) Insulin pump therapy vs multiple daily injections in obese type 2 diabetic patients. Diabet Med 22: 1037–1046PubMedCrossRef Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I (2005) Insulin pump therapy vs multiple daily injections in obese type 2 diabetic patients. Diabet Med 22: 1037–1046PubMedCrossRef
8.
go back to reference Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA (2005) Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: a comparison with conventional insulin therapy. Saudi Med J 26: 918–922PubMed Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA (2005) Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: a comparison with conventional insulin therapy. Saudi Med J 26: 918–922PubMed
9.
go back to reference Retnakaran R, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B (2005) Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care 28: 1835–1836PubMedCrossRef Retnakaran R, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B (2005) Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care 28: 1835–1836PubMedCrossRef
10.
go back to reference Diniz Mde F, Diniz MT, Sanches SR, de Almeida Salgado PP, Valadao MM, Freitas CP, Vieira DJ (2004) Glycemic control in diabetic patients after bariatric surgery. Obes Surg 14: 1051–1055PubMedCrossRef Diniz Mde F, Diniz MT, Sanches SR, de Almeida Salgado PP, Valadao MM, Freitas CP, Vieira DJ (2004) Glycemic control in diabetic patients after bariatric surgery. Obes Surg 14: 1051–1055PubMedCrossRef
11.
go back to reference Dixon JB, Dixon AF, O’Brien PE (2003) Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Diabet Med 20: 127–134PubMedCrossRef Dixon JB, Dixon AF, O’Brien PE (2003) Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Diabet Med 20: 127–134PubMedCrossRef
12.
go back to reference Zarich SW (2005) The role of intensive glycemic control in the management of patients who have acute myocardial infarction (review). Cardiol Clin 23: 109–117PubMedCrossRef Zarich SW (2005) The role of intensive glycemic control in the management of patients who have acute myocardial infarction (review). Cardiol Clin 23: 109–117PubMedCrossRef
13.
go back to reference Talbot TR (2005) Diabetes mellitus and cardiothoracic surgical-site infections. Am J Infect Control 33: 353–359PubMedCrossRef Talbot TR (2005) Diabetes mellitus and cardiothoracic surgical-site infections. Am J Infect Control 33: 353–359PubMedCrossRef
14.
go back to reference Furnary AP, Gao G, Grunkemeier GL, et al. (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125: 1007–1021PubMedCrossRef Furnary AP, Gao G, Grunkemeier GL, et al. (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125: 1007–1021PubMedCrossRef
15.
go back to reference Krinsley J, Grissler B (2005) Intensive glycemic management in critically ill patients. Jt Comm J Qual Patient Saf 31: 308–312PubMed Krinsley J, Grissler B (2005) Intensive glycemic management in critically ill patients. Jt Comm J Qual Patient Saf 31: 308–312PubMed
16.
go back to reference Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67: 352–360, discussion 360–362PubMedCrossRef Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67: 352–360, discussion 360–362PubMedCrossRef
17.
go back to reference Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63: 356–361PubMedCrossRef Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63: 356–361PubMedCrossRef
18.
go back to reference Van den Berghe G, Wouters P, Weekers F, et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359–1367PubMedCrossRef Van den Berghe G, Wouters P, Weekers F, et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359–1367PubMedCrossRef
19.
go back to reference Furnary AP, Wu Y, Bookin SO (2004) Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10(Suppl 2): 2133 Furnary AP, Wu Y, Bookin SO (2004) Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10(Suppl 2): 2133
20.
go back to reference Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082–1088PubMedCrossRef Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082–1088PubMedCrossRef
21.
go back to reference Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89: 219–226 PubMedCrossRef Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89: 219–226 PubMedCrossRef
22.
go back to reference Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf Peeters C, Van den Berghe G (2005) Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365: 53–59PubMedCrossRef Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf Peeters C, Van den Berghe G (2005) Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365: 53–59PubMedCrossRef
23.
go back to reference Valensi P, Moura I, Le Magoarou M, Paries J, Perret G, Attali JR (1997) Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non–insulin-dependent overweight patients with poor glycaemic control despite maximal oral antidiabetic treatment. Diabetes Metab 23: 51–57PubMed Valensi P, Moura I, Le Magoarou M, Paries J, Perret G, Attali JR (1997) Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non–insulin-dependent overweight patients with poor glycaemic control despite maximal oral antidiabetic treatment. Diabetes Metab 23: 51–57PubMed
24.
go back to reference Wittgrove AC, Clark GW, Tremblay LJ (1994) Laparoscopic gastric bypass, Roux-en-Y. preliminary report of five cases. Obes Surg 4: 353–357PubMedCrossRef Wittgrove AC, Clark GW, Tremblay LJ (1994) Laparoscopic gastric bypass, Roux-en-Y. preliminary report of five cases. Obes Surg 4: 353–357PubMedCrossRef
25.
go back to reference Pories WJ, Swanson MS, MacDonald KG, et al. (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222: 339–352PubMedCrossRef Pories WJ, Swanson MS, MacDonald KG, et al. (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222: 339–352PubMedCrossRef
26.
go back to reference Buchwald H, Avidor Y, Braunwald E, Jensen M, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724–1737PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, Jensen M, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724–1737PubMedCrossRef
27.
go back to reference Persson GE, Thulin AJ (1991) Prevalence of gallstone disease in patients with diabetes mellitus: a case-control study. Eur J Surg 157: 579–582PubMed Persson GE, Thulin AJ (1991) Prevalence of gallstone disease in patients with diabetes mellitus: a case-control study. Eur J Surg 157: 579–582PubMed
28.
go back to reference Miller K, Hell E, Lang B, Lengauer E (2003) Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg 238: 697–702PubMedCrossRef Miller K, Hell E, Lang B, Lengauer E (2003) Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg 238: 697–702PubMedCrossRef
Metadata
Title
Continuous perioperative insulin infusion therapy for patients with type 2 diabetes undergoing bariatric surgery
Authors
R. Blackstone
J. Kieran
M. Davis
L. Rivera
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 8/2007
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-006-9100-0

Other articles of this Issue 8/2007

Surgical Endoscopy 8/2007 Go to the issue